
ACHIEVE LIFE SCIENCES, INC.
Nasdaq · In Vitro & In Vivo Diagnostic Substances
Company Overview
A concise company profile alongside the latest public filing activity.
Achieve Life Sciences is a clinical-stage pharmaceutical company developing cytisinicline, a smoking and vaping cessation treatment, and is advancing it through late-stage clinical trials toward regulatory approval.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Stewart Richard AlistairInsider | Sell | $175K | 20,626at $8.49 | Aug 19, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable ACHV activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.